Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis

Phase 4

Completed

• Conditions: Rheumatoid Arthritis

• Registration Number: NCT00234897
• Lead Sponsor: Abbott

Brief Summary

The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment

Detailed Description

Not available

Study Timeline

• Study Start: 2004-08
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-10-07
• Study First Posted: 2005-10-10
• Status Verified: 2007-08
• Last Update Submitted: 2007-08-28
• Last Update Posted: 2007-08-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1938

Inclusion Criteria

• Subject was age 18 or older and in good health (Investigator discretion) with a recent stable medical history.
• Subject, based on assessment of investigator, meets the definition of active RA

Exclusion Criteria

• Subject considered by the investigator, for any reason, to be an unsuitable candidate for the study
• Female subject who is pregnant or breast-feeding or considering becoming pregnant

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Patient reported outcomes, clinical response indicators.

Secondary Outcome Measures

Name	Time	Method
Subject reported assessments of disease activity, physician reported assessments of disease activity, safety parameters, clinical response indicators.

Trial Locations

Locations (1)

Global Medical Information - Abbott; 🇺🇸 North Chicago, Illinois, United States